NEUROFIBRILLARY PATHOLOGY IN PROGRESSIVE SUPRANUCLEAR PALSY (PSP)

被引:0
|
作者
CERVOSNAVARRO, J
SCHUMACHER, K
机构
来源
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 1994年 / 42期
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In progressive supranuclear palsy (PSP), globose neurofibrillary tangles (NFT) are found in the subcortical areas and occasionally in the central cortex and spinal cord. An inverse relationship was found between the degree of neuronal loss and the presence of NFT. It has been postulated that NFT comes first and atrophy as a secondary event. Others authors have reported that the neurologic findings are associated with the presence of carcinomas and the CNS changes can be assessed as a paraneoplastic effect. In PSP the neuritic changes are mainly located in the basal ganglia and composed of straight filaments and tubules, different from the paired helical filaments found in the Alzheimer's disease, suggesting that they are formed of a new type of fibrous protein. In addition immunohistochemistry preparations using antibodies against tau and ubiquitin reveal an antigenic profile similar to early NFT in dementia of Alzheimer's type. These findings support the hypothesis that these changes may reflect different types of non-specific cytoskeletal disorganization.
引用
收藏
页码:153 / 164
页数:12
相关论文
共 50 条
  • [21] Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy
    Kimiko Ito
    Kimihito Arai
    Yasumasa Yoshiyama
    Koichi Kashiwado
    Yumi Sakakibara
    Takamichi Hattori
    Acta Neuropathologica, 2008, 115
  • [22] Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy
    Ito, Kimiko
    Arai, Kimihito
    Yoshiyama, Yasumasa
    Kashiwado, Koichi
    Sakakibara, Yumi
    Hattori, Takamichi
    ACTA NEUROPATHOLOGICA, 2008, 115 (06) : 623 - 628
  • [23] White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases
    Armstrong, Richard A.
    CLINICAL NEUROPATHOLOGY, 2013, 32 (05) : 399 - 405
  • [24] Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants
    Lopez, G.
    Bayulkem, K.
    Hallett, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 134 (04): : 242 - 249
  • [25] ANTIGENIC CHARACTERISTICS OF NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSY
    GALLOWAY, PG
    NEUROSCIENCE LETTERS, 1988, 91 (02) : 148 - 153
  • [26] Correlates of Quality of Life in Progressive Supranuclear Palsy (PSP)
    Higginbotham, Lenora
    Johnson, Vanessa
    Pantelyat, Alexander
    NEUROLOGY, 2016, 86
  • [27] Olfactory function impairment in progressive supranuclear palsy (PSP)
    Muinjonoc, Bukhrom
    Giyazitdinova, Elvina
    Musayeva, Yulduz
    MOVEMENT DISORDERS, 2016, 31 : S87 - S87
  • [28] MRI and brainstem atrophy in progressive supranuclear palsy (PSP)
    Slowinski, Jerzy
    Imamura, Akiko
    Uitti, Ryan J.
    Strongosky, Audrey J.
    Pooley, Robert A.
    Dickson, Dennis W.
    Broderick, Daniel F.
    Wszolek, Zbigniew K.
    ANNALS OF NEUROLOGY, 2006, 60 : S77 - S77
  • [29] The Effects of Amantadine on the Progression of Progressive Supranuclear Palsy (PSP)
    Hiller, Amie
    Murchison, Charles
    Nichols, Jennifer
    Quinn, Joseph
    NEUROLOGY, 2018, 90
  • [30] Abnormalities of voice quality in progressive supranuclear palsy (PSP)
    Skodda, S.
    Groenheit, W.
    Schlegel, U.
    MOVEMENT DISORDERS, 2012, 27 : S395 - S395